NLRP3 and atherosclerosis: Additionally, future research should also consider the interaction between Olfr2 and NLRP3, and whether alternative molecular pathways or additional mechanisms within the Olfr2 pathway might contribute to Corilagin’s atherosclerosis-mitigating effects.